Showing results (11-20 of 56) with videos related to
Sort By:
Pageof 6
CNS Drugs|June 23, 2019
Post-Hoc Analyses of the Effects of Baseline Sleep Quality on SHP465 Mixed Amphetamine Salts Extended-Release Treatment Response in Adults with Attention-Deficit/Hyperactivity DisorderCraig B H Surman, Brigitte Robertson, Jie Chen, et al.Journal of Psychiatric Practice|May 31, 2024
Can Adverse Event Patterns Inform Shared Decision-Making in ADHD Treatment? A Systematic Review of Evidence From Registration Trials for FDA-Approved Treatments in AdultsJoseph B Bond, Daniel M Walsh, Craig B H SurmanChild Neuropsychology : a Journal on Normal and Abnormal Development in Childhood and Adolescence|March 28, 2017
Clinical and functional correlates of processing speed in pediatric Attention-Deficit/Hyperactivity Disorder: a systematic review and meta-analysisNathan E Cook, Ellen B Braaten, Craig B H SurmanCNS Drugs|October 21, 2017
Do Pharmaceuticals Improve Driving in Individuals with ADHD? A Review of the Literature and Evidence for Clinical PracticeCraig B H Surman, Ronna Fried, Lauren Rhodewalt, et al.Journal of Attention Disorders|January 17, 2024
Comparing Pharmacotherapies for ADHD in Adults: Evidence From Outcome-Focused Analysis of Food and Drug Administration Drug Label Registration TrialsCraig B H Surman, Daniel M Walsh, Joseph B BondEuropean Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|February 9, 2013
Do stimulants improve functioning in adults with ADHD? A review of the literatureCraig B H Surman, Paul G Hammerness, Katie Pion, et al.Journal of Attention Disorders|February 17, 2006
Adults with ADHD and sleep complaints: a pilot study identifying sleep-disordered breathing using polysomnography and sleep quality assessmentCraig B H Surman, Robert J Thomas, Megan Aleardi, et al.Journal of Attention Disorders|April 9, 2016
Investigating Resilience to Depression in Adults With ADHDLauren E Oddo, Laura E Knouse, Craig B H Surman, et al.Psychiatry (Edgmont (Pa. : Township))|June 10, 2010
Lisdexamfetamine dimesylate: the first prodrug stimulantDavid W GoodmanTherapeutics and Clinical Risk Management|April 12, 2013
Sustained treatment effect in attention-deficit/hyperactivity disorder: focus on long-term placebo-controlled randomized maintenance withdrawal and open-label studiesDavid W GoodmanPageof 6